Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 1/2 9Phase 4 4Phase NA 3Phase 3 3Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1Neoplasms 1NSCLC 1HER2-positive Colorectal Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Endometrial Neoplasms 1Colonic Neoplasms 1Advanced Malignancies 1Advanced Colorectal Cancer 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6Trifluridine 6Celecoxib 6atezolizumab 5XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × HMPL-013 × Clear all
NCT06497985 2026-03-19

A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients

Chipscreen Biosciences, Ltd.

Phase 3 Recruiting
430 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04322539 2025-04-04

FRESCO-2

Hutchmed

Phase 3 Completed
691 enrolled 26 charts 1 FDA
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02314819 2020-02-17

FRESCO

Hutchmed

Phase 3 Completed
416 enrolled 1 FDA
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡